Ethosuximide
Anticonvulsant (absence seizures)
Brand names: Zarontin
Oral health effects
Gingival bleeding / rare blood dyscrasia
Reports of gingival bleeding and rare bone-marrow suppression.
Clinical management: Investigate unexplained bleeding/ulceration; coordinate CBC with physician.
Severe mucocutaneous reactions (SJS/TEN, rare)
Rare but serious skin reactions such as Stevens-Johnson syndrome, with painful oral ulceration, are a label warning.
Clinical management: Ask about new rash, fever or mouth ulcers, especially in the first two months of therapy. Painful erosions of the lips and mouth with skin rash are a medical emergency: refer urgently to the physician and do not delay for dental treatment.
Gum overgrowth and tongue swelling
The label reports gum hypertrophy and swelling of the tongue.
Clinical management: Monitor for gingival enlargement and reinforce thorough plaque control, which limits overgrowth; document and refer persistent enlargement to the prescriber or a periodontist.
Sources
- Adverse drug events in the oral cavity. Yuan A, Woo SB. Oral surgery, oral medicine, oral pathology and oral radiology, 2015.
- Ethosuximide prescribing information (FDA label) Chartwell RX, LLC / DailyMed, 2024.
- A review and guide to drug-associated oral adverse effects-Oral mucosal and lichenoid reactions. Part 2. Teoh L, Moses G, McCullough MJ. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2019.